Another possible mechanism is that Smad4 deficiency can enhance the immunogenicity of tumor cells, significantly increasing the activation level of DCs, and this activation of DCs is not affected by the expression of tumor cell antigen-presenting genes, such as β2M [79]. The gene discussed is B2M; the disease is neoplasm.